We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Generic TriCor Agreement Allows Teva to Sell Early
Generic TriCor Agreement Allows Teva to Sell Early
December 9, 2009
Abbott Laboratories has reached a licensing agreement with Teva Pharmaceuticals USA allowing Teva to begin selling a generic version of Abbott’s
heart treatment TriCor as early as 2011.